What Vitamin D Level Counts as Deficient on a Blood Test?

What this actually measures

The test measures serum 25-hydroxyvitamin D, or 25(OH)D — the form vitamin D takes after a first conversion step in the liver. It is used as the status indicator because it circulates at much higher, more stable concentrations than the active hormone form (1,25-dihydroxyvitamin D), which the kidneys convert on demand and tightly regulate, so it does not reflect how much vitamin D is actually available in the body.

The number on your report depends on which guideline wrote it

A vitamin D blood test returns one number — your serum 25-hydroxyvitamin D, or 25(OH)D, usually in ng/mL or nmol/L. What gets printed next to it, the word “deficient” or “sufficient,” depends on which of two different U.S. frameworks your lab licensed its reference range from, and they don’t agree.

The National Academies (the body still widely known as the Institute of Medicine, which produced the underlying 2011 report) calls anything below 30 nmol/L — 12 ng/mL — deficient, and anything at or above 50 nmol/L (20 ng/mL) sufficient. The Endocrine Society’s clinical practice guideline draws both lines higher: deficient below 20 ng/mL, sufficient only above 30 ng/mL.

That leaves a wide band — roughly 12 to 30 ng/mL — where the same result is “fine” on one framework and “low” on the other. That band is not a small edge case. It is where a large share of adult results actually fall.

What the test is actually measuring

The test measures 25(OH)D specifically, not vitamin D in general and not the hormone your body actually uses. Vitamin D from skin synthesis or food is converted once in the liver into 25(OH)D, which then circulates and gets stored; the kidneys convert a small, tightly regulated fraction of that into the active hormone form on demand.

Labs test the storage form rather than the active hormone because the storage form sits at concentrations roughly a thousand times higher and doesn’t swing hour to hour, which makes it the practical, stable marker of status. A result of 25 ng/mL tells you about that reservoir. It says nothing directly about calcium, parathyroid hormone, or bone — those are separate tests, when they’re needed at all.

Two frameworks, two different jobs

The disagreement isn’t a data error on either side — it’s what each framework was built to answer.

A threshold built to protect the near-entirety of a treated clinical population will sit higher than one built to describe where most of a general population already lands. Neither framework is wrong about what it measured. They asked different questions and printed different answers, and a lab report rarely tells you which question it’s using.

Where the mix-up actually costs you something

This isn’t only a labeling curiosity. The units themselves are a second, more mundane trap: one nmol/L equals 0.4 ng/mL, so a bare “50” without a unit could mean 50 nmol/L (20 ng/mL — the bottom edge of sufficient under the National Academies’ scale) or 50 ng/mL (125 nmol/L — the edge of the range flagged for potential harm). Those are more than two-fold apart. Reading the unit on your own report, not just the number, is worth the ten seconds it takes.

The framework question matters more for anyone near the 20-30 ng/mL band, because that’s where the two systems genuinely disagree rather than merely using different units for the same verdict. Below 12 ng/mL, both frameworks agree something is low. Above 30 ng/mL, both agree it’s adequate. The contested territory sits specifically in between.

Does “normal” change by age?

Not in the way most searches expect. The reference bands above — deficient, at risk, sufficient — are applied the same way from early childhood through older adulthood in the National Academies’ framework; there isn’t a separate blood-level target for a 70-year-old than for a 30-year-old.

What does change with age is the daily amount recommended to reach that level, because skin becomes less efficient at synthesizing vitamin D from sunlight with age.

The U.S. and U.K. figures aren’t measuring different things — they reflect different judgments about how much dietary and supplemental intake most people need on top of what sunlight already provides, and the U.K.’s is set with its own limited winter sunlight in mind. The NHS advises that people with little sun exposure, who are housebound or in care, who cover most of their skin outdoors, or who have an African, African-Caribbean, or South Asian background consider a supplement year-round rather than seasonally, for that reason.

The 2024 update that most “get tested” advice hasn’t caught up with

The Endocrine Society’s most recent guideline, published in 2024, changes the practical advice more than either set of cutoffs does. It suggests against routine 25(OH)D screening in generally healthy adults, at any age, on the grounds that the levels that would produce a clinically meaningful benefit haven’t been established in trials — and notably, this newer guideline does not define its own deficiency or sufficiency cutoffs for disease-prevention purposes at all.

Instead of “test everyone, then treat the number,” it recommends supplementation without testing first for specific groups: children and adolescents, adults aged 75 and older, and people who are pregnant. The reasoning in each case is a specific outcome the guideline names — for older adults, a potential reduction in mortality risk; for pregnancy, a potential reduction in preeclampsia risk — rather than a target blood level.

That’s a meaningfully different message than “get your level checked to see if you’re deficient,” and it hasn’t filtered into most consumer health content, which still treats testing as the obvious first step for anyone curious about their status.

What actually moves the number

A handful of things reliably move a 25(OH)D result. Sun exposure is the largest lever for most people — skin synthesizes vitamin D from UVB, which weakens with high latitude, winter months, more skin coverage, sunscreen, and window glass, all of which block the relevant wavelength. Diet contributes less on its own in most diets, since few foods are naturally rich sources; fortified foods add a smaller, steadier amount.

A low result can also reflect something other than diet or sun. According to MedlinePlus, a low or deficient reading can point to trouble absorbing vitamin D from food — a sign of an underlying malabsorption disorder — to kidney or liver disease impairing the conversion steps described above, or to a medication that affects vitamin D levels. None of those are things a repeat test alone will sort out, which is part of why a persistently low number belongs in front of a clinician rather than just a second lab slip.

Why this is graded contested

The individual numbers here are not in doubt — both the National Academies’ figures and the Endocrine Society’s figures are published, named, and traceable to a specific guideline document. What’s contested is the answer to the actual question in the title: which number is the deficiency line.

Two named institutions, each credible within its own remit, drew that line in two different places for two different legitimate reasons, and the gap between their answers — roughly 12 to 30 ng/mL — is wide enough to reclassify a large share of ordinary results depending on which framework is doing the classifying. That’s not a case where the evidence is thin. It’s a case where reasonable, well-resourced bodies looked at similar evidence and made different judgment calls about where to draw a line, and both lines are still standing.

Read a “deficient” or “insufficient” label on a lab report as a statement about which framework the lab chose, not as a single settled fact about your body — and if the number surprises you, the more useful question to ask is which cutoff produced the label, not whether the label is correct.